DeepMed Research

IBSA Institut Biochimique SA

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1945-01-01

Employees: 1K

Market Cap: -

Website: http://www.ibsagroup.com

Clinical Trials

Pharmacokinetics of FSH and hCG After a Single Subcutaneous Injection of Gonadotropins-IBSA

Phase 1

Recruiting

Conditions: OVARIAN STIMULATION
Infertility

Interventions: Drug: Gonadotropins Subcutaneos

First Posted Date: 2025-01-17

Last Posted Date: 2025-01-17

Lead Sponsor: IBSA Institut Biochimique SA

Target Recruit Count: 28

Registration Number: NCT06781957

Locations: 🇨🇦
Syneos Health, Québec, Canada

Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA.

Phase 1

Recruiting

Conditions: Ovarian Stimulation
Infertility

Interventions: Drug: Gonadotropins Subcutaneous

First Posted Date: 2024-10-26

Last Posted Date: 2024-10-26

Lead Sponsor: IBSA Institut Biochimique SA

Target Recruit Count: 28

Registration Number: NCT06659692

Locations: 🇨🇦
Syneos Health, Québec, Canada

TreatMent Of Knee osTeoarthritis wIth chONdroitin Sulfate - the OA MOTION Study

Phase 3

Withdrawn

Conditions: Knee Osteoarthritis

Interventions: Other: Placebo
Drug: Chondroitin Sulfate Sodium

First Posted Date: 2022-12-01

Last Posted Date: 2023-10-05

Lead Sponsor: IBSA Institut Biochimique SA

Registration Number: NCT05632783

A New Sildenafil Oral Film in Patients with Erectile Dysfunction

Phase 3

Completed

Conditions: Erectile Dysfunction

Interventions: Drug: Placebo
Drug: Sildenafil Oral Film 25 mg, 50 mg, 75 mg or 100 mg

First Posted Date: 2022-08-08

Last Posted Date: 2025-03-24

Lead Sponsor: IBSA Institut Biochimique SA

Target Recruit Count: 488

Registration Number: NCT05490680

Locations: 🇺🇸
Urology Group of Southern California, Los Angeles, California, United States
🇺🇸
Clintex Research Group, Miami, Florida, United States
🇺🇸
Coral Research Clinic, Miami, Florida, United States

and more 15 locations

Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)

Phase 4

Terminated

Conditions: Congenital Hypothyroidism

Interventions: Drug: Tirosint®-SOL
Drug: Levothyroxine Sodium

First Posted Date: 2022-02-08

Last Posted Date: 2025-04-18

Lead Sponsor: IBSA Institut Biochimique SA

Target Recruit Count: 34

Registration Number: NCT05228184

Locations: 🇺🇸
CHOC Children's Hospital, Orange, California, United States
🇺🇸
Children's Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸
Children's Hospital of Atlanta, Atlanta, Georgia, United States

and more 9 locations

Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants with Minor Soft Tissue Injury

Phase 3

Completed

Conditions: Soft Tissue Injuries

Interventions: Drug: Licart™ (diclofenac epolamine) topical system

First Posted Date: 2021-12-29

Last Posted Date: 2024-12-10

Lead Sponsor: IBSA Institut Biochimique SA

Target Recruit Count: 151

Registration Number: NCT05171673

Locations: 🇺🇸
Applied Research Center, Little Rock, Arkansas, United States
🇺🇸
Atella Clinical Research, LLC., La Palma, California, United States
🇺🇸
University Clinical Research - Deland, LLC, Deland, Florida, United States

and more 7 locations

Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.

Phase 3

Recruiting

Conditions: Infertility

Interventions: Drug: Progesterone-IBSA Injectable Solution
Drug: Progesterone Vaginal Gel with Applicator
Drug: Placebo Vaginal gel with applicator
Drug: Placebo injectable solution

First Posted Date: 2020-09-16

Last Posted Date: 2025-04-04

Lead Sponsor: IBSA Institut Biochimique SA

Target Recruit Count: 680

Registration Number: NCT04549116

Locations: 🇺🇸
The Fertility Treatment Center, LLC, Tempe, Arizona, United States
🇺🇸
HRC Fertility, Encino, California, United States
🇺🇸
Kindbody, Los Angeles, California, United States

and more 18 locations

Comparative Bioavailability Study of Human Chorionic Gonadotropin (hCG)-IBSA Versus a Marketed hCG Formulation

Phase 1

Completed

Conditions: Infertility

Interventions: Drug: Recombinant hCG 6'500 IU
Drug: Human hCG 10'000 IU

First Posted Date: 2018-11-08

Last Posted Date: 2021-03-11

Lead Sponsor: IBSA Institut Biochimique SA

Target Recruit Count: 26

Registration Number: NCT03735030

Locations: 🇨🇭
CROSS Research SA, Arzo, Ticino, Switzerland

Prolutex in Frozen Embryo Transfer Cycles At the Blastocyst Stage (PROGEX)

Phase 2

Completed

Conditions: Infertility

Interventions: Drug: Progesterone subcutaneous
Drug: Progesterone Vaginal Product

First Posted Date: 2018-10-10

Last Posted Date: 2024-11-22

Lead Sponsor: IBSA Institut Biochimique SA

Target Recruit Count: 213

Registration Number: NCT03701490

Locations: 🇪🇸
Instituto Bernabeu Madrid, Madrid, Spain
🇪🇸
Instituto Bernabeu, Alicante, Spain
🇪🇸
Ginemed, Sevilla, Spain

A Study to Evaluate the Clinical Performance and Safety of an Intra-articular Hyaluronic Acid in Knee Osteoarthritis

Phase 3

Completed

Conditions: Knee Osteoarthritis

Interventions: Device: Placebo

First Posted Date: 2017-06-27

Last Posted Date: 2021-11-16

Lead Sponsor: IBSA Institut Biochimique SA

Target Recruit Count: 692

Registration Number: NCT03200288

Locations: 🇮🇹
Ospedale San Pietro - FATEBENEFRATELLI, Roma, Italy
🇩🇪
Klinische Forschung Berlin-Mitte GmbH, Berlin, Germany
🇵🇱
NZOZ VITAMED Gałaj i Cichomski Sp. j., Bydgoszcz, Poland

and more 28 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy